The global hepatitis B virus market is anticipated to grow at a considerable CAGR of 4.1% during the forecast period (2022-2028). The global hepatitis B virus market is likely to be driven by limited access to hepatitis B treatment and diagnostics in many resource-constrained settings, and the rising prevalence of hepatitis B infections, during the forecast period. As per the information provided by Hepatitis B Foundation approximately 1.5 million people become newly infected each year with this virus. These infections are difficult to identify early on and only become obvious after a few weeks. It is a condition that can start at birth and is primarily caused by blood transfusions, dialysis, and razor sharing in healthcare settings.
To Request a Sample of our Report on Hepatitis B Virus Market: https://www.omrglobal.com/request-sample/hepatitis-b-virus-market
Additionally, factors such as an increase in injectable drug users, increased awareness, the presence of unmet demand, and the anticipated launch of new medications are expected to drive market expansion. Pediatric combination vaccinations, which protect against several causal agents and thereby give separate immunizations, are becoming increasingly popular on the market. Moreover, the government’s expanding efforts to raise public knowledge about the benefits of the hepatitis B vaccine among inhabitants. For instance, on the occasion of World Hepatitis Day 2018, India’s Ministry of Health and Family Welfare unveiled the National Viral Hepatitis Control Program, which aims to eradicate HBV infection by 2030.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Distribution Channel
- By Treatment
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including Merck & Co. Inc., GlaxoSmithKline plc., Sanofi, Dynavax Technologies and LG Chem, and others.
(Get 15% Discount on Buying this Report)
A full Report of Global Incubator Devices Market is Available @ https://www.omrglobal.com/industry-reports/hepatitis-b-virus-market
Global Hepatitis B Virus Market Report Segment
By Type
- Acute
- Chronic
By Distribution Channel
- Online Pharmacies
- Offline Pharmacies
By Treatment
- Anti-Viral Drugs
- Vaccine
- Immune Modulator Drugs
Global Hepatitis B Virus Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Arbutus Biopharma
- Arrowhead Pharmaceuticals, Inc.
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- Janssen Global Services, LLC,
- Johnson & Johnson
- Novartis AG
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
